MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy
Authors
Keywords
-
Journal
EUROPEAN RADIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-17
DOI
10.1007/s00330-019-06565-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer
- (2019) Inês Santiago et al. EUROPEAN RADIOLOGY
- Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer
- (2018) J. K. Jang et al. BRITISH JOURNAL OF SURGERY
- Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment
- (2018) Medhat Aker et al. Abdominal Radiology
- Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
- (2018) Yanfen Cui et al. EUROPEAN RADIOLOGY
- Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer
- (2018) Marc J. Gollub et al. EUROPEAN RADIOLOGY
- Can a Longer Waiting Period After Neoadjuvant Chemoradiotherapy Improve the Pathologic Complete Response Rate in Patients With Rectal Cancer?
- (2017) Jun Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial
- (2017) Eric Rullier et al. LANCET
- A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial
- (2017) Nick J. Battersby et al. Trials
- Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model
- (2016) Nicholas J. Battersby et al. ANNALS OF SURGERY
- Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer
- (2016) Fausto Petrelli et al. ANNALS OF SURGERY
- Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer
- (2016) B Creavin et al. BRITISH JOURNAL OF CANCER
- Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy
- (2016) Jemma Bhoday et al. DISEASES OF THE COLON & RECTUM
- Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
- (2016) Jérémie H. Lefevre et al. JOURNAL OF CLINICAL ONCOLOGY
- Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis
- (2016) Andrew G Renehan et al. LANCET ONCOLOGY
- Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy
- (2016) Elsa Iannicelli et al. Abdominal Radiology
- Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?
- (2013) S. Sassen et al. EUROPEAN RADIOLOGY
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Nonoperative Management of Rectal Cancer With Complete Clinical Response After Neoadjuvant Therapy
- (2012) James D. Smith et al. ANNALS OF SURGERY
- MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy
- (2012) J.M. Franklin et al. CLINICAL RADIOLOGY
- Bivariate meta-analysis of predictive values of diagnostic tests can be an alternative to bivariate meta-analysis of sensitivity and specificity
- (2012) Mariska M.G. Leeflang et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study
- (2011) Doenja M. J. Lambregts et al. ANNALS OF SURGICAL ONCOLOGY
- Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience
- (2011) Uday B. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
- (2010) Monique Maas et al. LANCET ONCOLOGY
- Locally Advanced Rectal Cancer: MR Imaging for Restaging after Neoadjuvant Radiation Therapy with Concomitant Chemotherapy Part I. Are We Able to Predict Tumor Confined to the Rectal Wall?
- (2009) Raphaëla C. Dresen et al. RADIOLOGY
- Locally Advanced Rectal Cancer: MR Imaging in Prediction of Response after Preoperative Chemotherapy and Radiation Therapy
- (2009) Brunella Barbaro et al. RADIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started